vs

Side-by-side financial comparison of Invesco (IVZ) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.

Tapestry, Inc. is the larger business by last-quarter revenue ($2.5B vs $1.7B, roughly 1.5× Invesco). Tapestry, Inc. runs the higher net margin — 22.4% vs -58.9%, a 81.3% gap on every dollar of revenue. On growth, Tapestry, Inc. posted the faster year-over-year revenue change (14.0% vs 6.2%). Tapestry, Inc. produced more free cash flow last quarter ($1.0B vs $432.2M). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (29.9% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.

IVZ vs TPR — Head-to-Head

Bigger by revenue
TPR
TPR
1.5× larger
TPR
$2.5B
$1.7B
IVZ
Growing faster (revenue YoY)
TPR
TPR
+7.8% gap
TPR
14.0%
6.2%
IVZ
Higher net margin
TPR
TPR
81.3% more per $
TPR
22.4%
-58.9%
IVZ
More free cash flow
TPR
TPR
$605.3M more FCF
TPR
$1.0B
$432.2M
IVZ
Faster 2-yr revenue CAGR
TPR
TPR
Annualised
TPR
29.9%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IVZ
IVZ
TPR
TPR
Revenue
$1.7B
$2.5B
Net Profit
$-995.9M
$561.3M
Gross Margin
75.5%
Operating Margin
-86.2%
28.6%
Net Margin
-58.9%
22.4%
Revenue YoY
6.2%
14.0%
Net Profit YoY
-575.8%
80.8%
EPS (diluted)
$-2.61
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
TPR
TPR
Q4 25
$1.7B
$2.5B
Q3 25
$1.6B
$1.7B
Q2 25
$1.5B
$1.7B
Q1 25
$1.5B
$1.6B
Q4 24
$1.6B
$2.2B
Q3 24
$1.5B
$1.5B
Q2 24
$1.5B
$1.6B
Q1 24
$1.5B
$1.5B
Net Profit
IVZ
IVZ
TPR
TPR
Q4 25
$-995.9M
$561.3M
Q3 25
$356.4M
$274.8M
Q2 25
$197.4M
$-517.1M
Q1 25
$171.1M
$203.3M
Q4 24
$209.3M
$310.4M
Q3 24
$55.0M
$186.6M
Q2 24
$132.2M
$159.3M
Q1 24
$141.5M
$139.4M
Gross Margin
IVZ
IVZ
TPR
TPR
Q4 25
75.5%
Q3 25
76.3%
Q2 25
76.3%
Q1 25
76.1%
Q4 24
74.4%
Q3 24
75.3%
Q2 24
74.9%
Q1 24
74.7%
Operating Margin
IVZ
IVZ
TPR
TPR
Q4 25
-86.2%
28.6%
Q3 25
16.5%
19.3%
Q2 25
14.1%
-33.9%
Q1 25
18.1%
16.0%
Q4 24
19.6%
22.4%
Q3 24
6.6%
16.7%
Q2 24
13.9%
14.8%
Q1 24
14.4%
13.8%
Net Margin
IVZ
IVZ
TPR
TPR
Q4 25
-58.9%
22.4%
Q3 25
21.7%
16.1%
Q2 25
13.0%
-30.0%
Q1 25
11.2%
12.8%
Q4 24
13.1%
14.1%
Q3 24
3.6%
12.4%
Q2 24
8.9%
10.0%
Q1 24
9.6%
9.4%
EPS (diluted)
IVZ
IVZ
TPR
TPR
Q4 25
$-2.61
$2.68
Q3 25
$0.66
$1.28
Q2 25
$-0.03
$-2.30
Q1 25
$0.38
$0.95
Q4 24
$0.46
$1.38
Q3 24
$0.12
$0.79
Q2 24
$0.29
$0.67
Q1 24
$0.31
$0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
TPR
TPR
Cash + ST InvestmentsLiquidity on hand
$1.0B
$1.1B
Total DebtLower is stronger
$1.8B
$2.4B
Stockholders' EquityBook value
$12.2B
$551.2M
Total Assets
$27.1B
$6.5B
Debt / EquityLower = less leverage
0.15×
4.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
TPR
TPR
Q4 25
$1.0B
$1.1B
Q3 25
$973.1M
$743.2M
Q2 25
$922.7M
$1.1B
Q1 25
$821.7M
$1.1B
Q4 24
$986.5M
$1.0B
Q3 24
$1.0B
$7.3B
Q2 24
$878.5M
$7.2B
Q1 24
$895.7M
$7.4B
Total Debt
IVZ
IVZ
TPR
TPR
Q4 25
$1.8B
$2.4B
Q3 25
$1.6B
$2.4B
Q2 25
$1.9B
$2.4B
Q1 25
$964.8M
$2.4B
Q4 24
$890.6M
$2.4B
Q3 24
$890.3M
$7.0B
Q2 24
$890.1M
$6.9B
Q1 24
$1.3B
$7.7B
Stockholders' Equity
IVZ
IVZ
TPR
TPR
Q4 25
$12.2B
$551.2M
Q3 25
$14.0B
$399.5M
Q2 25
$13.9B
$857.8M
Q1 25
$14.7B
$1.5B
Q4 24
$14.6B
$1.3B
Q3 24
$14.8B
$3.0B
Q2 24
$14.6B
$2.9B
Q1 24
$14.6B
$2.8B
Total Assets
IVZ
IVZ
TPR
TPR
Q4 25
$27.1B
$6.5B
Q3 25
$28.4B
$6.4B
Q2 25
$28.5B
$6.6B
Q1 25
$28.1B
$7.3B
Q4 24
$27.0B
$7.3B
Q3 24
$27.5B
$13.7B
Q2 24
$27.2B
$13.4B
Q1 24
$28.1B
$13.7B
Debt / Equity
IVZ
IVZ
TPR
TPR
Q4 25
0.15×
4.32×
Q3 25
0.12×
5.95×
Q2 25
0.14×
2.77×
Q1 25
0.07×
1.59×
Q4 24
0.06×
1.78×
Q3 24
0.06×
2.35×
Q2 24
0.06×
2.39×
Q1 24
0.09×
2.77×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
TPR
TPR
Operating Cash FlowLast quarter
$455.8M
$1.1B
Free Cash FlowOCF − Capex
$432.2M
$1.0B
FCF MarginFCF / Revenue
25.5%
41.5%
Capex IntensityCapex / Revenue
1.4%
1.7%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$1.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
TPR
TPR
Q4 25
$455.8M
$1.1B
Q3 25
$606.2M
$112.6M
Q2 25
$547.9M
$446.8M
Q1 25
$-84.6M
$144.3M
Q4 24
$316.9M
$506.0M
Q3 24
$438.4M
$119.5M
Q2 24
$489.1M
$256.0M
Q1 24
$-54.4M
$97.8M
Free Cash Flow
IVZ
IVZ
TPR
TPR
Q4 25
$432.2M
$1.0B
Q3 25
$586.4M
$80.2M
Q2 25
$530.4M
$411.5M
Q1 25
$-108.0M
$113.4M
Q4 24
$309.9M
$475.1M
Q3 24
$410.0M
$93.9M
Q2 24
$462.4M
$209.8M
Q1 24
$-75.4M
$78.8M
FCF Margin
IVZ
IVZ
TPR
TPR
Q4 25
25.5%
41.5%
Q3 25
35.7%
4.7%
Q2 25
35.0%
23.9%
Q1 25
-7.1%
7.2%
Q4 24
19.5%
21.6%
Q3 24
27.1%
6.2%
Q2 24
31.2%
13.2%
Q1 24
-5.1%
5.3%
Capex Intensity
IVZ
IVZ
TPR
TPR
Q4 25
1.4%
1.7%
Q3 25
1.2%
1.9%
Q2 25
1.2%
2.0%
Q1 25
1.5%
2.0%
Q4 24
0.4%
1.4%
Q3 24
1.9%
1.7%
Q2 24
1.8%
2.9%
Q1 24
1.4%
1.3%
Cash Conversion
IVZ
IVZ
TPR
TPR
Q4 25
1.93×
Q3 25
1.70×
0.41×
Q2 25
2.78×
Q1 25
-0.49×
0.71×
Q4 24
1.51×
1.63×
Q3 24
7.97×
0.64×
Q2 24
3.70×
1.61×
Q1 24
-0.38×
0.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

TPR
TPR

Coach$1.4B57%
Other$787.0M31%
Kate Spade Company$290.0M12%

Related Comparisons